Skip to main content

Find Clinical Trials

Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Robot-assisted Approach to Cervical Cancer

NCT03719547

Conditions: Cervical Cancer, Disease Attributes, Female Urogenital Diseases, +15 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Recruiting

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

NCT07026994

Conditions: Amyloidosis, Brain Diseases, Cardiovascular Diseases, +18 more
Locations: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

West China Hospital, Sichuan University Chengdu, China

Huashan Hospital, Fudan University Shanghai, China

View Trial Details

Recruiting

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

NCT07001540

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

NCT06996132

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

NCT07014449

Conditions: AML (Acute Myelogenous Leukemia, Adult Acute Myeloid Leukemia, C-Myc, +16 more
Locations: The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

NCT06063681

Conditions: Advanced / Metastatic Solid Tumor, Disease Attributes, Neoplasm Metastasis, +5 more
Locations: Scientia Clinical Research Ltd Randwick, New South Wales, Australia

Monash Health Clayton, Victoria, Australia

Peninsula & South Eastern Haematology & Oncology Group Frankston, Victoria, Australia

View Trial Details

Recruiting

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

NCT06859775

Conditions: Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

NCT06987916

Conditions: B Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Shanghai Tongji Hospital ( Tongji Hospital of Tongji University) Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

NCT06414148

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Royal Brisbane and Women's Hospital Herston, Queensland, Australia

Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Recruiting

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

NCT06547528

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan

Nagoya University Hospital Nagoya, Aichi-ken, Japan

Akita University Hospital Akita, Japan

National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan

View all 14 locations

View Trial Details